azacitidine has been researched along with Di Guglielmo Disease in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (36.36) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Bejar, R; Diep, D; González-Avalos, E; Huang, Y; Lee, M; Lio, CJ; Luger, T; Park, S; Rao, A; Reilly, BM; Tanaka, T; Wheeler, EC; Williamson, L; Zhang, K | 1 |
| Ades, L; Al-Ali, H; Almeida, AM; Autzinger, EM; Bargay, J; Bonanad, S; Burgstaller, S; Costa, MJ; Deben, G; Diez-Campelo, M; Esteves, S; Falantes, JF; Fenaux, P; Garrido, A; Geissler, D; Greil, R; Itzykson, R; Krippl, P; Lang, A; Maurillo, L; Musto, P; Pedro, C; Pinto, R; Pleyer, L; Prebet, T; Ramos, F; Sekeres, MA; Shammo, J; Sperr, WR; Stauder, R; Thepot, S; Valent, P; Van De Loosdrecht, AA; Wetzel, J | 1 |
| Thakral, B; Wang, SA | 1 |
| Curik, N; Dluhosova, M; Jonasova, A; Stopka, T; Vargova, J; Zikmund, T | 1 |
| Garcia-Manero, G; Goswami, M; Hasserjian, RP; Jabbour, EJ; Medeiros, LJ; Patel, KP; Peng, J; Tang, G; Wang, SA | 1 |
| Dufva, IH; Hansen, SB; Kjeldsen, L | 1 |
| Arai, S; Hangai, S; Honda, A; Ichikawa, M; Kamikubo, Y; Kurokawa, M; Nakagawa, M; Nakamura, F | 1 |
| Angelillo-Scherrer, A; Blum, S | 1 |
| Angeloni, D; Braga, E; Danilkovitch-Miagkova, A; Ivanova, T; Lerman, MI; Zabarovsky, E | 1 |
| Fernández-Nestosa, MJ; Hernández, P; Krimer, DB; Schvartzman, JB | 1 |
| Decal, DL; Whittington, KB; Zucker, RM | 1 |
| Christman, JK | 1 |
| Barbieri, R; del Senno, L; Fantoni, A; Gambari, R; Raschellà, G; Tripodi, M; Viola, L | 1 |
| Anagnou, NP; Anderson, WF; Chiang, YL; Haidaris, D; Ley, TJ; Wilson, VL | 1 |
| Chen, YL; Wu, RT | 1 |
| Chernoff, N; Elstein, KH; Lau, C; Rogers, JM; Shuey, DL; Zucker, RM | 1 |
| Chiang, Y; Davis, RG; Vishwanatha, JK | 1 |
| Ding, BC; Heng, H; Hukku, B; Matherly, LH; Witt, TL; Zhang, L | 1 |
| Feldmesser, E; Kafri, T; Razin, A; Szyf, M | 1 |
| Hickey, I; Jones, S; O'Neill, K | 1 |
| Barbieri, R; Biagini, R; Gambari, R; Viola, L | 1 |
| Barbieri, R; Fisher, PB; Gambari, R; Giacomini, P; Natali, PG; Piva, R; Tecce, R | 1 |
1 review(s) available for azacitidine and Di Guglielmo Disease
| Article | Year |
|---|---|
DNA methylation in friend erythroleukemia cells: the effects of chemically induced differentiation and of treatment with inhibitors of DNA methylation.
Topics: 5-Methylcytosine; Animals; Azacitidine; Cell Differentiation; Cell Line; Cytosine; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA, Neoplasm; Friend murine leukemia virus; Gene Expression Regulation; Globins; Leukemia, Erythroblastic, Acute; Methylation; Mice | 1984 |
21 other study(ies) available for azacitidine and Di Guglielmo Disease
| Article | Year |
|---|---|
5-Azacytidine Transiently Restores Dysregulated Erythroid Differentiation Gene Expression in TET2-Deficient Erythroleukemia Cells.
Topics: Azacitidine; Cell Differentiation; Dioxygenases; DNA-Binding Proteins; Gene Expression; Humans; Leukemia, Erythroblastic, Acute | 2021 |
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Biomarkers; Bone Marrow; Cytogenetic Analysis; Decitabine; Female; Humans; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Treatment Outcome | 2017 |
"Hof" in pronormoblasts: pure erythroid leukemia mimicking plasma cell myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cyclophosphamide; Cytoplasm; Dexamethasone; Diagnostic Errors; Erythroblasts; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Leukemia, Erythroblastic, Acute; Male; Multiple Myeloma; Myelodysplastic Syndromes; Thalidomide | 2017 |
Epigenetic control of SPI1 gene by CTCF and ISWI ATPase SMARCA5.
Topics: Acute Disease; Adenosine Triphosphatases; Animals; Azacitidine; CCCTC-Binding Factor; Cell Line, Tumor; Chromosomal Proteins, Non-Histone; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genomic Imprinting; HeLa Cells; Humans; Immunoblotting; Insulin-Like Growth Factor II; K562 Cells; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Microscopy, Confocal; Protein Binding; Proto-Oncogene Proteins; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Long Noncoding; Trans-Activators | 2014 |
Myelodysplastic syndromes following therapy with hypomethylating agents (HMAs): development of acute erythroleukemia may not influence assessment of treatment response.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Biopsy; Bone Marrow; Chromosome Aberrations; Decitabine; DNA Methylation; Female; Humans; In Situ Hybridization, Fluorescence; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Survival Analysis; Treatment Outcome; Young Adult | 2016 |
Durable complete remission after azacitidine treatment in a patient with erythroleukaemia.
Topics: Aged; Antineoplastic Agents; Azacitidine; Humans; Leukemia, Erythroblastic, Acute; Male; Remission Induction | 2012 |
Erythroleukemia showing early erythroid and cytogenetic responses to azacitidine therapy.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Pharmacological; Cytogenetic Analysis; Erythroid Cells; Humans; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Time Factors; Treatment Outcome | 2013 |
Block of red blood cell maturation in acute erythroid leukemia.
Topics: Antigens, CD; Azacitidine; Blood Cell Count; Cell Differentiation; Erythroblasts; Fatal Outcome; Humans; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Pancytopenia; Polycythemia Vera; Reticulocytes | 2012 |
Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter.
Topics: Azacitidine; Cells, Cultured; CpG Islands; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Erythroblastic, Acute; Lung Neoplasms; Promoter Regions, Genetic; Receptor Protein-Tyrosine Kinases; Transcription, Genetic; Transgenes | 2007 |
PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells.
Topics: Acetamides; Animals; Azacitidine; Cell Differentiation; Decitabine; Drug Resistance; Erythroid Cells; Friend murine leukemia virus; GATA1 Transcription Factor; Genes, myc; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Mice; Proto-Oncogene Proteins; RNA, Small Interfering; Trans-Activators; Tumor Cells, Cultured | 2008 |
5-Azacytidine increases the synthesis of embryonic hemoglobin (E2) in murine erythroleukemic cells.
Topics: Animals; Azacitidine; Butyrates; Butyric Acid; Cell Differentiation; Dimethyl Sulfoxide; Fetal Hemoglobin; Friend murine leukemia virus; Gene Expression Regulation; Hemoglobins; Isoelectric Focusing; Leukemia, Erythroblastic, Acute; Mice; Protein Biosynthesis | 1983 |
Human leukemia K-562 cells: induction of erythroid differentiation by 5-azacytidine.
Topics: Azacitidine; Cell Differentiation; Cell Line; Deoxyribonuclease HpaII; DNA; DNA Restriction Enzymes; Erythrocytes; Fetal Hemoglobin; Gene Expression Regulation; Globins; Hemoglobins; Hemoglobins, Abnormal; Humans; Leukemia, Erythroblastic, Acute; Methylation; RNA, Messenger | 1984 |
DNA methylation and regulation of the human beta-globin-like genes in mouse erythroleukemia cells containing human chromosome 11.
Topics: Acetamides; Animals; Azacitidine; Cell Line; Chromosomes, Human, 6-12 and X; DNA; Gene Expression Regulation; Globins; Humans; Hybrid Cells; Leukemia, Erythroblastic, Acute; Methylation; Mice; RNA, Messenger | 1984 |
Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
Topics: Aspartate-tRNA Ligase; Azacitidine; Butyrates; Butyric Acid; Cell Differentiation; Cell Division; Cell Line; Cytarabine; Guanine; Hemin; Humans; Kinetics; Leukemia, Erythroblastic, Acute; RNA, Transfer, Amino Acyl; RNA, Transfer, Asp; RNA, Transfer, His; RNA, Transfer, Tyr; Time Factors; Tumor Cells, Cultured | 1994 |
Utility of the murine erythroleukemic cell (MELC) in assessing mechanisms of action of DNA-active developmental toxicants: application to 5-fluorouracil.
Topics: Animals; Azacitidine; Cell Cycle; Cell Survival; Culture Techniques; Cyclophosphamide; Decitabine; DNA; Fetus; Fluorouracil; Leukemia, Erythroblastic, Acute; Mice; Teratogens; Thymidylate Synthase; Toxicology; Tumor Cells, Cultured | 1993 |
Altered expression of annexin II in human B-cell lymphoma cell lines.
Topics: Alkaline Phosphatase; Annexin A2; Azacitidine; B-Lymphocytes; Cell Nucleus; Decitabine; DNA Modification Methylases; Enzyme Inhibitors; Gene Expression; Humans; Immune Sera; Leukemia, Erythroblastic, Acute; Lymphoma, B-Cell; Phosphorylation; RNA, Messenger; Tumor Cells, Cultured | 1996 |
Association of deletions and translocation of the reduced folate carrier gene with profound loss of gene expression in methotrexate-resistant K562 human erythroleukemia cells.
Topics: 5' Untranslated Regions; Antimetabolites, Antineoplastic; Azacitidine; Biological Transport; Carrier Proteins; Decitabine; DNA Methylation; Drug Resistance, Neoplasm; Gene Deletion; Gene Expression Regulation, Neoplastic; Genes, Reporter; Histones; Humans; Hydroxamic Acids; In Situ Hybridization, Fluorescence; K562 Cells; Karyotyping; Leukemia, Erythroblastic, Acute; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Promoter Regions, Genetic; Reduced Folate Carrier Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Translocation, Genetic | 2001 |
Cell specific DNA methylation patterns; formation and a nucleosome locking model for their function.
Topics: Animals; Azacitidine; Cell Line; Dimethyl Sulfoxide; DNA, Neoplasm; Kinetics; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Methylation; Mice; Models, Genetic; Nucleosomes; Thrombin | 1985 |
Azacytidine induces reversion of thymidine kinase deficiency in Friend erythroleukemia cells.
Topics: Alleles; Animals; Azacitidine; Cell Line; Clone Cells; DNA; Dose-Response Relationship, Drug; Friend murine leukemia virus; Gene Expression Regulation; Leukemia, Erythroblastic, Acute; Methylation; Mice; Thymidine Kinase | 1986 |
Inhibition of hemoglobin accumulation by monoclonal antibodies to the human transferrin receptor is reversed by hemin.
Topics: Animals; Antibodies, Monoclonal; Azacitidine; Cell Differentiation; Cell Line; Heme; Hemoglobins; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Mice; Receptors, Transferrin | 1987 |
Regulation of the expression of class II genes of the human major histocompatibility complex in tumor cells.
Topics: Azacitidine; B-Lymphocytes; DNA, Neoplasm; Gene Expression Regulation; Genes, MHC Class II; HLA-D Antigens; HLA-DR Antigens; Humans; Interferons; Leukemia, Erythroblastic, Acute; Major Histocompatibility Complex; Melanoma; Methylation; Recombinant Proteins; Tumor Cells, Cultured | 1987 |